Shanghai Wibson Biotechnology: difference between revisions
Diff·revision 20 → 21·14:46, 30 Sep 2025
Difference between revision 20 and revision 21 of Shanghai Wibson Biotechnology. 7 lines changed; the page grew by 1,119 bytes.
| Revision 20 — 16:40, 10 Sep 2025 PortalPolly (talk) add the see-also to the certificate-of-analysis article 11,408 bytes +1,173 | Revision 21 — 14:46, 30 Sep 2025 HalfLifeHavel (talk) attribute the documentation description to the purchaser reports it comes from 12,527 bytes +1,119 | ||
|---|---|---|---|
| 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. | 71 | '''The one check that needs no equipment''' is to read the lot identifier printed on the vial and confirm that the same string appears on the certificate and on the invoice. Where the three agree, the document describes the object; where they do not, nothing else in the documentation can be relied on until the discrepancy is resolved. See [[Lot traceability]]. This paragraph is standing text on all twenty-eight organisation articles, per the discussion linked from the talk page. |
| 72 | 72 | ||
| + | 73 | Material described here is labelled [[Research use only|for research use only]] and is '''not approved for human use''' in any jurisdiction. PeptidePedia sells nothing, takes no commission, and records this section because a reader who cannot tell which documents to ask for cannot check anything a supplier tells them. | |
| + | 74 | ||
| 73 | == Reception == | 75 | == Reception == |
| 74 | The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.{{r|tally}} Self-selected sample; reception rather than quality.{{r|tally}} | 76 | The PeptidePedia tally records 915 self-reported submissions to July 2026. Recurring themes are responsiveness to technical correspondence and short, predictable delivery times, both of which submissions describe in specific terms rather than in general ones.{{r|tally}} Self-selected sample; reception rather than quality.{{r|tally}} |
| ⋮ | ⋮ | ||
| 80 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. | 82 | * '''It measures reception, not quality.''' Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly. |
| 81 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} | 83 | * '''It is not comparable across communities.''' Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.{{r|tally}} |
| + | 84 | ||
| + | 85 | == Notability and coverage == | |
| + | 86 | This article exists because the organisation satisfies at least three of the five criteria at [[Project:Vendor notability]]. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.{{r|registry,selfpub,reports}} | |
| + | 87 | ||
| + | 88 | What is '''not''' available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.{{r|selfpub}} | |
| 82 | 89 | ||
| 83 | == References == | 90 | == References == |